Prostate News Archive
18-Oct-2008
Prostate Cancer: Biomarkers - Coverage From The 60th Annual Congress Of The German Urological Association (Medical News Today)
STUTTGART, GERMANY (UroToday.com) - The value of PCA3 in urine was investigated in a prospective European trial on 463 patients who had previously undergone one or two negative prostate biopsies and who were scheduled for a re-biopsy of their prostate. In 128 patients prostate cancer was found on re-biopsy. The area under the curve was 0.658 for PCA3 compared to 0.578 for free PSA. Additional Risk Factors for Prostate Cancer Shown (WEEK-TV Peoria)
Doctors have - for years -recommended men get a prostate cancer screening after the age of fifty. Researchers have known for years that some men are more likely to develop prostate cancer than others. Big Donation for Prostate Cancer (Voice of the Common Man)
The Avalon Chapter of the Motorcycle Ride for Dad has announced over 61-thousand dollars in funds for prostate cancer research and education. Positive Phase II Data on Cougar Biotechnology's CB7630 Presented at Prostate Cancer Foundation Scientific Retreat (Centre Daily Times)
Cougar Biotechnology, Inc. (NASDAQ:CGRB) today announced that results from an ongoing Phase II clinical trial of Cougar's investigational drug CB7630 (abiraterone acetate) were presented today at the prostate Cancer Foundation Scientific Retreat. The prostate Cancer Foundation Scientific Retreat is currently taking place in Lake Tahoe, Nevada.
Back to Prostate News Archive
